Drug Type Small molecule drug |
Synonyms ACY-1497, RCY-1497 |
Target |
Mechanism HDAC1 inhibitors(Histone deacetylase 1 inhibitors), HDAC2 inhibitors(Histone deacetylase 2 inhibitors), Hemoglobin gamma chain stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Regenacy Pharmaceuticals LLCStartup |
Active Organization- |
Inactive Organization Regenacy Pharmaceuticals LLCStartup |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Discovery | US | Regenacy Pharmaceuticals LLCStartup | - |
Beta-Thalassemia | Discovery | US | Regenacy Pharmaceuticals LLCStartup | - |